Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N L Eberhardt

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
The Journal of Clinical Endocrinology and Metabolism|August 12, 1999
Leptin and leptin receptor expression in normal and neoplastic human pituitary: evidence of a regulatory role for leptin on pituitary cell proliferationL Jin, B G Burguera, M E Couce, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1979
Regulation of activity of chromatin receptors for thyroid hormone: possible involvement of histone-like proteinsN L Eberhardt, J C Ring, L K Johnson, et al.
Oncogene|August 26, 1998
Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumorsJ S Zhang, M Nelson, B McIver, et al.
Laboratory Animals|April 12, 2011
Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation modelsM C Deeds, J M Anderson, A S Armstrong, et al.
Cancer Gene Therapy|April 20, 2013
Redifferentiation and induction of tumor suppressors miR-122 and miR-375 by the PAX8/PPARγ fusion protein inhibits anaplastic thyroid cancer: a novel therapeutic strategyH V Reddi, C B Driscoll, P Madde, et al.
Cancer Gene Therapy|June 28, 2008
ONYX-411, a conditionally replicative oncolytic adenovirus, induces cell death in anaplastic thyroid carcinoma cell lines and suppresses the growth of xenograft tumors in nude miceH V Reddi, P Madde, A J Reichert-Eberhardt, et al.
DNA (Mary Ann Liebert, Inc.)|January 1, 1984
Expression and hormonal regulation of the rat growth hormone gene in transfected mouse L cellsM Karin, N L Eberhardt, S H Mellon, et al.
Clinical Endocrinology|June 10, 2000
FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significanceB McIver, S K Grebe, L Wang, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1993
Congenital gigantism due to growth hormone-releasing hormone excess and pituitary hyperplasia with adenomatous transformationD Zimmerman, W F Young, M J Ebersold, et al.
Cancer Gene Therapy|July 14, 2012
Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapyH V Reddi, P Madde, S J McDonough, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
The Journal of Clinical Endocrinology and Metabolism|August 12, 1999
Leptin and leptin receptor expression in normal and neoplastic human pituitary: evidence of a regulatory role for leptin on pituitary cell proliferationL Jin, B G Burguera, M E Couce, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1979
Regulation of activity of chromatin receptors for thyroid hormone: possible involvement of histone-like proteinsN L Eberhardt, J C Ring, L K Johnson, et al.
Oncogene|August 26, 1998
Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumorsJ S Zhang, M Nelson, B McIver, et al.
Laboratory Animals|April 12, 2011
Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation modelsM C Deeds, J M Anderson, A S Armstrong, et al.
Cancer Gene Therapy|April 20, 2013
Redifferentiation and induction of tumor suppressors miR-122 and miR-375 by the PAX8/PPARγ fusion protein inhibits anaplastic thyroid cancer: a novel therapeutic strategyH V Reddi, C B Driscoll, P Madde, et al.
Cancer Gene Therapy|June 28, 2008
ONYX-411, a conditionally replicative oncolytic adenovirus, induces cell death in anaplastic thyroid carcinoma cell lines and suppresses the growth of xenograft tumors in nude miceH V Reddi, P Madde, A J Reichert-Eberhardt, et al.
DNA (Mary Ann Liebert, Inc.)|January 1, 1984
Expression and hormonal regulation of the rat growth hormone gene in transfected mouse L cellsM Karin, N L Eberhardt, S H Mellon, et al.
Clinical Endocrinology|June 10, 2000
FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significanceB McIver, S K Grebe, L Wang, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1993
Congenital gigantism due to growth hormone-releasing hormone excess and pituitary hyperplasia with adenomatous transformationD Zimmerman, W F Young, M J Ebersold, et al.
Cancer Gene Therapy|July 14, 2012
Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapyH V Reddi, P Madde, S J McDonough, et al.
Pageof 9